As reported in Healio, A multistakeholder approach is needed to ensure complete enrollment of seven randomized clinical trials that will test the comparative clinical effectiveness of proton therapy, according to a report published in Journal of Clinical Oncology. If...
As reported in GenomeWeb, Strata Oncology said today that it will help identify patients for the National Cancer Institute’s Molecular Analysis for Therapy Choice (NCI-MATCH) precision medicine trial. Launched in 2015, NCI-MATCH is testing the efficacy of cancer...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
